- Home
- BFRI vs CDIO Comparison
BFRI vs CDIO Comparison
Compare BFRI & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- CDIO
- Stock Information
- Founded
- BFRI 1997
- CDIO 2017
- Country
- BFRI United States
- CDIO United States
- Employees
- BFRI N/A
- CDIO N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BFRI Health Care
- CDIO Health Care
- Exchange
- BFRI Nasdaq
- CDIO Nasdaq
- Market Cap
- BFRI 7.9M
- CDIO 6.4M
- IPO Year
- BFRI 2021
- CDIO N/A
- Fundamental
- Price
- BFRI $0.87
- CDIO $4.50
- Analyst Decision
- BFRI Strong Buy
- CDIO Buy
- Analyst Count
- BFRI 1
- CDIO 1
- Target Price
- BFRI $2.75
- CDIO $60.00
- AVG Volume (30 Days)
- BFRI 216.4K
- CDIO 39.0K
- Earning Date
- BFRI 08-13-2025
- CDIO 08-11-2025
- Dividend Yield
- BFRI N/A
- CDIO N/A
- EPS Growth
- BFRI N/A
- CDIO N/A
- EPS
- BFRI N/A
- CDIO N/A
- Revenue
- BFRI $37,997,000.00
- CDIO $19,902.00
- Revenue This Year
- BFRI $11.75
- CDIO $1,434.82
- Revenue Next Year
- BFRI $17.09
- CDIO $4,661.91
- P/E Ratio
- BFRI N/A
- CDIO N/A
- Revenue Growth
- BFRI 14.28
- CDIO N/A
- 52 Week Low
- BFRI $0.54
- CDIO $3.22
- 52 Week High
- BFRI $2.22
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- BFRI 67.76
- CDIO 57.13
- Support Level
- BFRI $0.79
- CDIO $3.43
- Resistance Level
- BFRI $0.90
- CDIO $4.67
- Average True Range (ATR)
- BFRI 0.08
- CDIO 0.24
- MACD
- BFRI 0.01
- CDIO 0.21
- Stochastic Oscillator
- BFRI 81.19
- CDIO 100.00
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.